ENTERO (Mid Cap) Share Target 2025, 2026 To 2039
|
Entero Healthcare Solutions Limited |
|||
|
Price: ₹1,305.95 (-1.13%) | ||
| 52 Week Low: ₹970.00 52 Week High: ₹1,584.25 |
|||
| Market Capital: 5,658.97 Crore (Midcap) | |||
| Healthcare -> Medical Distribution | |||
Warning: Undefined variable $max_return in /usr/local/lsws/wordpress/wp-content/themes/Extra-child/template_LongTermTargets.php on line 1614
Warning: Undefined variable $max_return in /usr/local/lsws/wordpress/wp-content/themes/Extra-child/template_LongTermTargets.php on line 1616
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: ENTERO Share Price Target For 2025
- 1.1.1: ENTERO Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: ENTERO Share Price Target For 2026
- 1.2.1: ENTERO Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: ENTERO Share Price Target Chart and Table From 2025, 2026, 2027 to 2039
- 3: ENTERO Brief Company Overview
- 4: ENTERO Financial Performance
- 4.0.1: Is ENTERO A Good Buy For Long Term?
ENTERO, a Mid Cap company in the Medical Distribution Industry showing 23.3% quarterly revenue growth with 1.3% profit margin.
To predict the ENTERO's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
ENTERO Share Price Target For 2025
The line chart displays the monthly closing prices of ENTERO with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for ENTERO shares in 2025, see the table below.
ENTERO Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1429.0 (+9.42%) | Price Action: 09 Jan 2025 Low |
| 2025 Target 2 | 1414.05 (+8.27%) | Price Action: 02 Jan 2025 Low |
| 2025 Target 1 | 1398.2 (+7.06%) | Price Action: 07 Jan 2025 Low |
| Current Price | 1305.95 | ENTERO's share price as of 24 Jan 2025 |
| Stop Loss 1 | 1259.9 (-3.53%) | Price Action: 02 Aug 2024 High |
| Stop Loss 2 | 1245.3 (-4.65%) | Price Action: 13 Aug 2024 High |
| Stop Loss 3 | 1228.14 (-5.96%) | Technical Indicator: MA250 |
Short-Term Technical Outlook
Current Technical Position: ENTERO is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹1384.75 serves as the nearest technical reference point.
Historical Returns: 3-month: -5.2% | 6-month: +9.21% | 1-year: NA
ENTERO Share Price Target For 2026
The line chart displays the monthly closing prices of ENTERO with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for ENTERO shares in 2026, see the table below.
ENTERO Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 1762.06 (+34.92%) | Price Action: Chart |
| 2026 Target 2 | 1729.21 (+32.4%) | Fibonacci Extension Level 123.60% |
| 2026 Target 1 | 1704.6 (+30.52%) | Fibonacci Extension Level 64.90% |
| Current Price | 1305.95 | ENTERO's share price as of 24 Jan 2025 |
| Stop Loss 1 | 1210.5 (-7.31%) | Price Action: 14 Aug 2024 Low |
| Stop Loss 2 | 1198.0 (-8.27%) | Price Action: 20 Feb 2024 High |
| Stop Loss 3 | 1185.15 (-9.25%) | Price Action: 26 Feb 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: ENTERO is currently trading at 54.7% of its 52-week range (₹970 - ₹1584.25).
Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.
Long-Term Performance: 1-year: NA | 3-year: NA | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
ENTERO Share Price Target Chart and Table From 2025, 2026, 2027 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,305.95 | ||
| 2025 | ₹1,691.32 | +29.5% | ₹1,716.69 |
| 2026 | ₹2,046.90 | +21.02% | ₹2,077.60 |
| 2027 | ₹2,360.55 | +15.32% | ₹2,395.96 |
| 2028 | ₹2,596.08 | +9.97% | ₹2,635.02 |
| 2029 | ₹2,905.56 | +11.92% | ₹2,949.14 |
| 2030 | ₹3,288.81 | +13.19% | ₹3,338.14 |
| 2031 | ₹3,648.93 | +10.94% | ₹3,703.66 |
| 2032 | ₹3,958.02 | +8.47% | ₹4,017.39 |
| 2033 | ₹4,143.49 | +4.68% | ₹4,205.64 |
| 2034 | ₹4,495.36 | +8.49% | ₹4,562.79 |
| 2035 | ₹4,897.54 | +8.94% | ₹4,971.00 |
| 2036 | ₹5,250.96 | +7.21% | ₹5,329.72 |
| 2037 | ₹5,555.49 | +5.79% | ₹5,638.82 |
| 2038 | ₹5,701.91 | +2.63% | ₹5,787.44 |
| 2039 | ₹6,104.09 | +7.05% | ₹6,195.65 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
ENTERO Brief Company Overview
Entero Healthcare Solutions Limited: A Leading Healthcare Distributor in India Established in 2018, Entero Healthcare Solutions Limited has made a mark in the Indian healthcare industry. The Mumbai-based company specializes in the distribution of pharmaceutical and surgical...
products to retail pharmacies, hospitals, nursing homes, and healthcare clinics. Entero Healthcare Solutions Limited has earned a reputation for its extensive product range, catering to diverse healthcare needs. The company distributes: Medical devices Over-the-counter medical products Nutraceuticals Vaccines Entero Healthcare Solutions Limited is committed to providing quality healthcare products and services, partnering with leading manufacturers to ensure the highest standards.ENTERO Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 5,658.97 Crore | Market valuation of ENTERO's shares. |
| Revenue (TTM) | 4,132.18 Crore | Total revenue generated by ENTERO over the past twelve months. |
| Net Income (TTM) | +52.94 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +3.33% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +1.28% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+23.3% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+221.8% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
20.59 | Company's total debt divided by total shareholder equity. |
| Total Debt | 337.97 Crore | Sum of ENTERO's current & long-term financial obligations. |
| Total Cash | 893.18 Crore | Total amount of liquid funds available to ENTERO. |
Is ENTERO A Good Buy For Long Term?
ENTERO, a mid-cap stock with a market capitalization of ₹5,658.97 crore, shows mixed signals for long-term investment. While its Q2 2024-25 cash balance (₹893.18 crore) exceeds its debt (₹337.97 crore), a low profit margin of 1.28% and stagnant year-on-year returns raise concerns. Revenue growth of 23.3% (QoQ) is positive, but a 0% return over the past year and three years warrants caution. More analysis is needed before considering it a good long-term buy; it currently leans toward an average buy at best.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
